Cambridge Healthtech Institute’s Third Annual

Genomics in Medicine

Data-Driven Personalized Diagnostics for Improved Outcomes

February 19-20, 2015 | Moscone North Convention Center | San Francisco, CA
Part of the 22nd International Molecular Medicine Tri-Conference


The rapid decline in cost and widespread utilization of patient genomic information is now dramatically impacting clinical research—offering significant benefits to patients, clinicians, researchers and developers working to accurately diagnose pathologies and deliver personalized treatments. The Genomics in Medicine symposium will once again gather stakeholders to discuss advances highlighting the impact and clinical utility of patient sequencing; integration of genomics data into medical practice; identification, annotation and interpretation of variants; as well as sharing and mining data to guide treatment.


Keynote Presentation: Update on the MedSeq and BabySeq Projects: Randomized Trials of Sequencing in Adults and Newborns

Robert C. Green, M.D., MPH, Director, G2P Research Program; Associate Director, Research, Partners Center for Personalized Genetic Medicine, Division of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School

The Vision and the Reality: One Cancer Center’s Journey toward Genomic Medicine

Jeff Boyd, Ph.D., Senior Vice President, Molecular Medicine; The Robert C. Young., Chair in Cancer Research; Executive Director, Cancer Genome Institute; Chief, Division of Molecular Pathology; Professor, Cancer Biology Program, Fox Chase Cancer Center

The Impact of Genomic Variation in Clinical Development

Hakon Hakonarson, M.D., Ph.D., Director, Center for Applied Genomics, Children’s Hospital of Philadelphia


Integration of Genomics into Medical Practice: Educational Challenges

Bruce R. Korf, M.D., Ph.D., Wayne H. and Sara Crews Finley Chair in Medical Genetics; Professor and Chair, Department of Genetics; Director, Heflin Center for Genomic Sciences, University of Alabama at Birmingham

Navigating the Genome: Realizing the True Promise of Genomic Medicine in the Clinic

James Evans, M.D., Ph.D., Bryson Distinguished Professor, Genetics and Medicine, Department of Genetics, University of North Carolina School of Medicine


Genomic Approaches to Causal Variant Identification

Gregory Cooper, Ph.D., Faculty Investigator, HudsonAlpha Institute for Biotechnology

Decoding the Patient’s Genome: Clinical Use of Genome-Wide Sequencing Data

Elizabeth Worthey, Ph.D., Assistant Professor, Pediatrics & Bioinformatics Program, Human & Molecular Genetics Center, Medical College of Wisconsin

Clinical Grade Annotations: Public Data Resources for Interpreting Genomic Variants

Gabe Rudy, Vice President, Product Development, Golden Helix


Rapid Genome Sequencing, Interpretation and Management in the Neonatal Intensive Care Unit

Euan Ashley, D.Phil., Associate Professor, Medicine and Genetics; Director, Stanford Center for Inherited Cardiovascular Disease, Stanford University School of Medicine

Reinterpreting Results from Large-Scale Clinical Sequencing or Genetic Testing

Peter Byers, M.D., Director, Center for Precision Diagnostics; Professor, Pathology, Medicine & Genome Sciences, University of Washington School of Medicine

The Clinical Ramifications of Divergent Oncogenic Pathways in Tumor Evolution

Hanlee Ji, M.D., Assistant Professor, Division of Oncology, Department of Medicine, Stanford University School of Medicine; Senior Associate Director, Stanford Genome Technology Center



Sharing and Mining Patient Data

Impact & Utilization of Integrating Genomics Data into EMRs

Dan Roden, M.D., William Stokes Professor, Experimental Therapeutics; Professor, Medicine and Pharmacology; Assistant Vice Chancellor, Personalized Medicine, Vanderbilt University

Mining Clinical Genomics Data

Joel Dudley, Ph.D., Director, Biomedical Informatics; Assistant Professor of Genetics and Genomic Sciences Icahn School of Medicine at Mount Sinai

The ClinGen Resource: Sharing Data. Building Knowledge. Improving Care.

Christa Lese Martin, Ph.D., FACMG, Director & Senior Investigator, Autism & Developmental Medicine Institute (ADMI), Geisinger Health System

Technological Advances in NGS Diagnostics

Paradigm Cancer Diagnostic (PCDx): Development of a Clinical-Grade Next-Generation Sequencing Test for Cancer Patients

Robert Penny, M.D., Ph.D., CEO, Paradigm

Enabling Translational Diagnostics through Discovery and Development of Signatures with Unified DNA and RNA NGS Panels

Brian Haynes, Ph.D., Senior Scientist, Asuragen

For partnering and sponsorship information, please contact:
Jon Stroup (Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483

Joseph Vacca (Companies L-Z)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431



  2015 Plenary Sessions 

2015 MMTC Prelim Agenda 

Premier Sponsors:


Jackson Laboratory - small logo 

Leica Biosystems 




Thomson Reuters-Large 

Local Partners:




City of SSF